Top Industry Leaders in the Olanzapine Market
Latest Olanzapine Companies Updates:
Teva and Royalty Pharma Collaboration In October 2023, Teva Pharmaceuticals partnered with Royalty Pharma to accelerate the development of Olanzapine LAI (TEV-'749), a long-acting injectable form of the drug for schizophrenia. Royalty Pharma provided up to $100 million for ongoing development costs, with Phase 3 data expected in the second half of 2024.
SteadyTeq Platform Teva is utilizing the SteadyTeq platform, used for another antipsychotic, to deliver Olanzapine LAI. This technology aims to improve medication adherence and reduce hospitalizations.
List of Olanzapine Key companies in the market:
- Dr ready’s laboratory.
- Watson pharmaceuticals
- Lilly
- Hamson pharmaceuticals
- Sun pharmaceuticals
- Sandoz pharmaceuticals
- Torrent pharmaceuticals
- Jubilant lifescientist